Pediatrix Medical Group Enters Material Definitive Agreement
Ticker: MD · Form: 8-K · Filed: Apr 25, 2024 · CIK: 893949
Sentiment: neutral
Topics: material-definitive-agreement
Related Tickers: MD
TL;DR
Pediatrix (MD) signed a big deal. Details TBD.
AI Summary
On April 19, 2024, Pediatrix Medical Group, Inc. entered into a material definitive agreement. The filing does not provide specific details about the agreement, its terms, or any involved parties beyond the company itself.
Why It Matters
This filing indicates a significant new contract or partnership for Pediatrix Medical Group, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — The lack of specific details in the filing creates uncertainty about the nature and potential impact of the material definitive agreement.
Key Players & Entities
- Pediatrix Medical Group, Inc. (company) — Registrant
- MEDNAX, INC. (company) — Former company name
- PEDIATRIX MEDICAL GROUP INC (company) — Former company name
FAQ
What is the nature of the material definitive agreement entered into by Pediatrix Medical Group, Inc.?
The filing does not specify the nature of the material definitive agreement.
Who are the other parties involved in this material definitive agreement?
The filing does not disclose the names of any other parties involved in the agreement.
What is the effective date of this material definitive agreement?
The earliest event reported is April 19, 2024, which is the date of the report and likely the effective date or date of entry into the agreement.
Does this agreement involve any financial commitments or changes to Pediatrix Medical Group's financial structure?
The filing does not provide any details regarding financial commitments or structural changes related to the agreement.
Are there any immediate operational impacts expected from this agreement?
The filing does not mention any immediate operational impacts resulting from the material definitive agreement.
Filing Stats: 693 words · 3 min read · ~2 pages · Grade level 13.7 · Accepted 2024-04-25 16:31:03
Filing Documents
- md-20240419.htm (8-K) — 37KB
- img260267938_0.jpg (GRAPHIC) — 309KB
- 0000950170-24-048387.txt ( ) — 910KB
- md-20240419.xsd (EX-101.SCH) — 23KB
- md-20240419_htm.xml (XML) — 4KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement. On April 19, 2024, Pediatrix Medical Group, Inc., a Florida corporation (the "Company"), through PMG Services, Inc., a Florida corporation and wholly-owned subsidiary of the Company ("PMG Services"), entered into a Master Services Agreement (the "Agreement") with Guidehouse Managed Services LLC ("Guidehouse"), a Delaware limited liability company, pursuant to which Guidehouse will provide certain enterprise revenue cycle management services for the Company. The Agreement contains customary representations, warranties and covenants of PMG Services and Guidehouse, including indemnities for certain third-party claims, subject to certain limitations. Each of PMG Services and Guidehouse may terminate the Agreement prior to the end of its eight-year term for material breach, insolvency, fraud or regulatory exclusions, subject to certain notice and cure periods, and PMG Services may terminate the Agreement upon certain regulatory events or changes in law. The Agreement also provides for successive two-year extension terms unless either party delivers a notice of non-renewal at least 12 months prior to the end of the initial term or extension term, as applicable. The Company may terminate the Agreement without cause upon 180 days' prior written notice during any such extension term. Under the terms of the Agreement, PMG Services will pay Guidehouse and Guidehouse Inc. certain fees as set forth in statements of work to be entered into between the parties from time to time. Pursuant to statement of work #1 entered into between the parties, Guidehouse will provide certain services for a one year term, in exchange for the payment by PMG Services of (i) fees based on a set monthly amount per Guidehouse employee exclusively assigned to the Company, (ii) base advisory fees and (iii) advisory performance fees based on Guidehouse's achievement of certain performance metrics, in each case as calculated in accordance therewit
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Pediatrix Medical Group, Inc. Date: April 25, 2024 By: /s/ C. Marc Richards C. Marc Richards Chief Financial Officer